TRAQinform IQ vs Illumeo System
AI Verdict
Choose TRAQinform IQ if…
Choose TRAQinform IQ if your primary need is highly precise, quantitative analysis of lesions in PET/CT scans for oncology and nuclear medicine. This tool is ideal for clinicians focused on accurately monitoring disease progression and treatment response through automated segmentation and detailed reporting of lesion volume and tracer uptake changes.
View TRAQinform IQ →Choose Illumeo System if…
Choose Illumeo System if you require a comprehensive imaging and informatics platform with adaptive AI to enhance overall radiology workflow efficiency and reduce variability across your institution. This system is best suited for augmenting clinician skills, integrating seamlessly with existing PACS/EMR/RIS, and providing contextual awareness and dynamic reporting across various imaging modalities.
View Illumeo System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | TRAQinform IQ | Illumeo System |
|---|---|---|
| Pricing | Unknown | Not publicly available |
| Deployment | SaaS; cloud-based; on prem; hybrid; web browser access | Integrates with existing healthcare IT systems (e.g., Philips IntelliSpace PACS, EMR/RIS); Enterprise viewer is HTML5-based and zero-footprint. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Illumeo SystemPhilips Illumeo System emphasizes an adaptive intelligence that augments clinicians' skills and redefines how they interact with images, anticipating user needs and offering contextual awareness. Its HTML5-based, zero-footprint viewer and reported benefits in streamlining screen real estate and improving turnaround times suggest a superior focus on user experience and workflow integration.
Clinical Value
TRAQinform IQTRAQinform IQ provides highly specific and quantitative analysis of lesions in PET/CT scans for oncology and nuclear medicine, with strong clinical validation demonstrating superior prognostication of overall survival compared to standard-of-care methods. The recent approval of a Category III CPT code by the AMA further underscores its distinct clinical contribution and value in providing lesion-level analysis for advanced metastatic cancer.
Pricing & Value
TRAQinform IQNeither tool provides public pricing information, making a direct cost comparison impossible. However, TRAQinform IQ's recent achievement of a Category III CPT code from the AMA significantly enhances its value proposition by facilitating insurance and Medicare reimbursement, which is a critical factor for broader clinical adoption and financial viability for healthcare providers.
Enterprise Readiness
Illumeo SystemBoth tools are HIPAA compliant and offer BAAs, with TRAQinform IQ providing flexible deployment options. However, Philips Illumeo System, as a product from a major global health technology leader, benefits from Philips' extensive ecosystem of enterprise imaging solutions and established integrations with existing PACS/EMR/RIS, offering a more comprehensive and trusted enterprise-level solution.
Innovation
Illumeo SystemIllumeo System's 'Adaptive Intelligence' that learns and anticipates radiologist preferences, combined with contextual awareness and an intelligent clinical semantic labeling engine, represents a more groundbreaking approach to human-AI interaction in imaging. While TRAQinform IQ offers innovative quantitative analysis, Illumeo's adaptive and interactive paradigm pushes the boundaries of AI integration into broader clinical workflows.
Support & Docs
Illumeo SystemThe provided information does not explicitly detail support or documentation for either tool. However, given Philips' status as a large, established global healthcare technology company, it is highly probable that the Illumeo System benefits from a more extensive and robust customer support infrastructure, training programs, and comprehensive documentation compared to a smaller company like AIQ Global.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | TRAQinform IQ | Illumeo System |
|---|---|---|
| Product Name | TRAQinform IQ | Illumeo System |
| Company | AIQ Global | Philips Medical Systems Technologies |
| Tagline | Advanced AI for Quantitative Oncology Treatment Response | Adaptive Intelligence Technology for Radiology |
| Description | FDA-cleared, cloud-based AI software tool that provides quantitative analysis of lesions in PET/CT scans, aiding clinicians in monitoring disease progression and treatment response in oncology and nuclear medicine. | Imaging and informatics platform with adaptive intelligence (AI) that augments clinicians' skills and redefines how they interact with images, enhancing their expertise and efficiency, and supporting variability reduction throughout the institution. |
| Categories | Oncology AI, Radiology & Imaging AI | Radiology & Imaging AI |
| Specialties | Nuclear Medicine, Oncology, Radiology | Interventional Radiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring TRAQinform IQ and Illumeo System.